| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/24/2014 | WO2014113413A1 Bcl-2bcl-xl inhibitors and therapeutic methods using the same |
| 07/24/2014 | WO2014113388A1 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
| 07/24/2014 | WO2014111496A1 3-substituted pyrazoles and use as dlk inhibitors |
| 07/24/2014 | WO2014111069A1 Helquat derivatives, preparation thereof, and use thereof as medicaments |
| 07/24/2014 | US20140206878 Methods for preparing oxazolidinones and compositions containing them |
| 07/24/2014 | US20140206877 Novel intermediate and process useful in the preparation of -(2-chlorophenyl)-methanone |
| 07/24/2014 | US20140206876 2-(Substituted ethynyl)quinoline Derivatives as mGLUr5 Antagonists |
| 07/24/2014 | US20140206873 Process for Manufacturing 5-Chloromethyl-2,3-Pyridine Dicarboxylic Acid Anhydrides |
| 07/24/2014 | US20140206865 Human Adam-10 Inhibitors |
| 07/24/2014 | US20140206709 Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 07/24/2014 | US20140206707 6-alkyl-n-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 07/24/2014 | US20140206706 Five-membered heterocycles useful as serine protease inhibitors |
| 07/24/2014 | US20140206701 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/24/2014 | US20140206694 Heterocyclic compounds and their uses |
| 07/24/2014 | US20140206690 Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| 07/24/2014 | US20140206689 Modulators of atp-binding cassette transporters |
| 07/24/2014 | US20140206686 Phthalazinones and isoquinolinones as rock inhibitors |
| 07/24/2014 | US20140206676 Substituted 4-(1h-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of machr m1 receptors |
| 07/24/2014 | US20140206673 Therapeutically active compositions and their methods of use |
| 07/24/2014 | US20140206660 Phenyl-Heteroaryl Derivatives and Methods of Use Thereof |
| 07/24/2014 | US20140206647 Pyrimidinecarboxamides as cxcr2 modulators |
| 07/24/2014 | US20140206585 Substituted Diarylamines and Use of Same as Antioxidants |
| 07/24/2014 | US20140205596 Organic compounds |
| 07/24/2014 | US20140205595 Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonists |
| 07/24/2014 | US20140205537 Lrrk2 inhibitors |
| 07/23/2014 | EP2757103A1 Pyrrolidine-3-ylacetic acid derivative |
| 07/23/2014 | EP2757096A1 Inhibitors of human immunodeficiency virus replication |
| 07/23/2014 | EP2755965A1 Novel imidazole amines as modulators of kinase activity |
| 07/23/2014 | EP2755964A1 Sulfonic acid salts of heterocyclylamide-substituted imidazoles |
| 07/23/2014 | EP2755963A1 New dihydroquinoline-2-one derivatives |
| 07/23/2014 | EP2755962A1 Azaindazoles |
| 07/23/2014 | EP2755958A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 07/23/2014 | EP2755956A1 Disubstituted 5-fluoro-pyrimidines |
| 07/23/2014 | EP2755953A1 3 -pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
| 07/23/2014 | EP2755952A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
| 07/23/2014 | EP2755951A1 Plant growth regulating compounds |
| 07/23/2014 | EP2755950A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
| 07/23/2014 | CN103946220A 含有片段{2-[4-(联苯-4-基)-1h-咪唑-2-基]吡咯烷-1-羰基甲基}胺的杆状丙型肝炎病毒抑制剂 Fragments containing the {2- [4- (biphenyl-4-yl) -1h- imidazol-2-yl] pyrrolidine-1-carbonyl-methyl} amine rod-hepatitis C virus inhibitors |
| 07/23/2014 | CN103946213A 作为组织蛋白酶抑制剂的新吡咯烷衍生物 Cathepsin inhibitors as new pyrrolidine derivatives |
| 07/23/2014 | CN103945845A 作为前药的达比加群-偕胺肟酸酯及其作为药物的用途 As a prodrug dabigatran - amidoxime esters and their use as medicaments |
| 07/23/2014 | CN103937485A 橙色磷光oled材料 Orange phosphorescent material oled |
| 07/23/2014 | CN103936792A 含有吡唑结构单元的化合物 Pyrazole compounds containing the structural unit |
| 07/23/2014 | CN103936720A 含有螺芴结构单元的化合物及其制备方法与应用 Compound and its preparation method and application of structural units containing spirofluorene |
| 07/23/2014 | CN103936719A 苯并咪唑类衍生物制备方法及用途 Method for preparing benzimidazole-derivatives and uses |
| 07/23/2014 | CN103936718A 一种高纯度delafloxacin的制备方法 Method for preparing a high purity delafloxacin |
| 07/23/2014 | CN103936717A 一种delafloxacin中间体及其制备方法 An intermediate and preparation method delafloxacin |
| 07/23/2014 | CN103936716A 具蕈毒碱受体拮抗剂和β2肾上腺素受体激动剂活性的二酰胺化合物 A muscarinic receptor antagonist and β2 adrenergic receptor agonist activity of the diamide compound |
| 07/23/2014 | CN103936715A 一种埃索美拉唑钠的精制方法及合成方法 Refined method of esomeprazole sodium and synthetic methods |
| 07/23/2014 | CN103936714A 一种埃索美拉唑镁的制备方法 A method for preparing esomeprazole magnesium |
| 07/23/2014 | CN103936713A 双磺酰胺类化合物及其制备方法和用途 Dual sulfonamide compounds and their preparation and use |
| 07/23/2014 | CN103936712A 酰胺类化合物及其制备方法和用途 Lactam compounds and their preparation and use |
| 07/23/2014 | CN103936674A 一类含“5-三氟甲基-4-吡唑酰胺”结构的苯甲酰胺或酰腙衍生物及其应用 A Class "5-trifluoromethyl-4-pyrazolyl amide" structure benzamide or hydrazone derivatives and their application |
| 07/23/2014 | CN103936650A 酰亚胺类苯基哌嗪衍生物及其盐、制备方法和用途 Imides phenylpiperazine derivatives and salts thereof, a preparation method and uses |
| 07/23/2014 | CN103936538A 一种催化氧化芳硼类化合物制备酚的方法 A catalytic oxidation of an aromatic boron compound of the preparation method of a phenol |
| 07/23/2014 | CN103304542B 一种富马酸卢帕他定化合物 One kind of fumaric acid compound rupatadine |
| 07/23/2014 | CN103044393B 一种1-(3-氯-2-吡啶基)-1h-吡唑-5-甲酸酯的合成方法 One kind of 1- (3-chloro-2-pyridinyl) -1h- synthesis of pyrazole-5-carboxylic acid ester |
| 07/23/2014 | CN102993181B 埃索美拉唑的制备方法及埃索美拉唑盐的制备方法 Esomeprazole preparation method and preparation method esomeprazole salt |
| 07/23/2014 | CN102942431B 一种利用分子筛分离手性化合物的方法 A molecular sieve separation of chiral compounds utilizing methods |
| 07/23/2014 | CN102884048B 用作hcn阻滞剂的氨基杂芳基衍生物 Blockers used hcn amino heteroaryl derivatives |
| 07/23/2014 | CN102807560B 不对称催化氧化合成埃索美拉唑的方法 Asymmetric Catalytic Oxidation Method esomeprazole |
| 07/23/2014 | CN102666489B 鞘氨醇激酶抑制剂 Sphingosine kinase inhibitors |
| 07/23/2014 | CN102351842B 甲磺酸伊马替尼的f、g、h、i 和k晶形 Imatinib mesylate f, g, h, i, and k-crystalline |
| 07/23/2014 | CN102317280B 具有胃动素受体激动活性的羟基吲哚衍生物 Has a motilin receptor agonist hydroxy indole derivatives |
| 07/23/2014 | CN102285970B 一种埃索美拉唑化合物、制备方法及其药物组合物 One kind of esomeprazole compounds, preparation and pharmaceutical compositions thereof |
| 07/23/2014 | CN102197032B 杂环pim-激酶抑制剂 Heterocyclic pim- kinase inhibitor |
| 07/23/2014 | CN102177141B 作为丙型肝炎病毒抑制剂的联-1h-苯并咪唑 As inhibitors of hepatitis C virus associated -1h--benzimidazole |
| 07/23/2014 | CN102108076B 制备无定形右兰索拉唑的方法 Amorphous dexlansoprazole prepared |
| 07/23/2014 | CN102105462B 可用作c-met的抑制剂的酰胺基苯氧基吲唑 Useful as inhibitors of c-met phenoxy indazole amide |
| 07/23/2014 | CN102105437B 金刚烷基二酰胺衍生物及其应用 Adamantyl diamide derivatives and their Applications |
| 07/23/2014 | CN101663289B 作为多巴胺d4受体拮抗剂的哌嗪基-丙基-吡唑衍生物和包含它们的药物组合物 Dopamine receptor antagonists as d4 piperazinyl - propyl - pyrazole derivatives and pharmaceutical compositions containing them |
| 07/23/2014 | CN101622240B 稠合取代氨基吡咯烷衍生物 Fused to an amino-substituted pyrrolidine derivatives |
| 07/22/2014 | US8785647 Pesticidal arylpyrrolidines |
| 07/22/2014 | US8785646 Process for producing amide compound |
| 07/22/2014 | US8785644 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds |
| 07/22/2014 | US8785643 Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors |
| 07/22/2014 | US8785635 Cyclopamine analogs |
| 07/22/2014 | US8785634 Spiropiperidine prolylcarboxypeptidase inhibitors |
| 07/22/2014 | US8785632 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 07/22/2014 | US8785628 Triazine derivatives as kinase inhibitors |
| 07/22/2014 | US8785490 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 07/22/2014 | US8785489 Heteroaryl substituted indole compounds useful as MMP-13 inhibitors |
| 07/22/2014 | US8785478 Viral polymerase inhibitors |
| 07/22/2014 | US8785474 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions |
| 07/22/2014 | US8785470 Heterocyclic compounds and uses thereof |
| 07/22/2014 | US8785468 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions |
| 07/22/2014 | US8785464 Pyrimidine derivatives that inhibit FAK/PTK2 |
| 07/22/2014 | US8785459 Quinazoline compounds as kinase inhibitors |
| 07/22/2014 | US8785450 Therapeutic compounds and compositions |
| 07/22/2014 | US8785449 Carboxamide compounds and methods for using the same |
| 07/22/2014 | US8785447 Use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders |
| 07/22/2014 | US8785442 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| 07/22/2014 | US8785439 2,5,7-substituted oxazolopyrimidine derivatives |
| 07/22/2014 | US8785372 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 07/22/2014 | US8785003 Material for organic electroluminescence device and organic electroluminescence device using the same |
| 07/22/2014 | US8784789 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 07/22/2014 | CA2762960C Recrystallization processes for obtaining anhydrous optically active lansoprazole |
| 07/17/2014 | WO2014110574A1 Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
| 07/17/2014 | WO2014110322A2 Substituted dioxopiperidinyl phthalimide derivatives |
| 07/17/2014 | WO2014110297A1 (hetero) arylacetamide derivatives as antiretroviral agents |
| 07/17/2014 | WO2014110086A2 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof |